当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析

尔康制药

(300267)

  

流通市值:48.79亿  总市值:70.75亿
流通股本:14.22亿   总股本:20.63亿

尔康制药(300267)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润0.29亿元,每股收益0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益441544.80万元,未分配利润120372.55万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产504989.09万元,负债63444.29万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入681,881,688.38353,547,866.171,139,612,276.29854,289,240.97
营业总成本656,655,615.53338,072,474.371,213,768,146.03893,553,175.63
其他经营收益
营业利润32,112,145.2626,228,298.64-370,608,077.22-20,299,504.02
利润总额32,053,479.3826,586,884.54-388,117,806.27-23,697,483.58
净利润28,810,557.5423,942,043.19-392,626,872.67-26,889,704.7
每股收益
其他综合收益-15,845,203.45-11,550,621.21-15,464,320.82-85,012,752.5
综合收益总额12,965,354.0912,391,421.98-408,091,193.49-111,902,457.2
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,615,999,351.771,676,715,416.551,717,081,656.361,679,049,957.44
非流动资产:
非流动资产合计3,433,891,528.963,447,614,260.363,482,652,834.833,715,043,022.42
资产总计5,049,890,880.735,124,329,676.915,199,734,491.195,394,092,979.86
流动负债:
流动负债合计533,867,935.14618,820,138.93705,342,064.26626,942,140.73
非流动负债:
非流动负债合计100,574,984.1290,750,430.5192,198,616.4468,801,548.93
负债合计634,442,919.26709,570,569.44797,540,680.7695,743,689.66
所有者权益(或股东权益):
归属于母公司股东权益合计4,469,540,895.524,464,244,106.54,447,425,532.364,725,838,323.3
股东权益合计4,415,447,961.474,414,759,107.474,402,193,810.494,698,349,290.2
负债和股东权益合计5,049,890,880.735,124,329,676.915,199,734,491.195,394,092,979.86
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计805,749,020.76344,190,570.111,252,255,073.92952,090,602.49
经营活动现金流出小计759,906,773.23348,339,077.011,085,563,367876,276,362.27
经营活动产生的现金流量净额45,842,247.53-4,148,506.9166,691,706.9275,814,240.22
投资活动产生的现金流量:
投资活动现金流入小计344,066,779.96103,008,332.8212,514,361.74213,219,361.74
投资活动现金流出小计449,007,926.1929,637,797.69534,669,337.8474,507,107.01
投资活动产生的现金流量净额-104,941,146.2373,370,535.11-322,154,976.06-261,287,745.27
筹资活动产生的现金流量:
筹资活动现金流入小计410,000,000170,000,000796,080,000507,700,000
筹资活动现金流出小计475,915,412.21230,554,397.7654,935,595.34369,526,492.94
筹资活动产生的现金流量净额-65,915,412.21-60,554,397.7141,144,404.66138,173,507.06
汇率变动对现金及现金等价物的影响-1,555,462.31-1,106,513.25-6,409,837.1-9,550,453.85
现金及现金等价物净增加额-126,569,773.227,561,117.26-20,728,701.58-56,850,451.84
期末现金及现金等价物余额363,339,251.56497,470,142.04489,909,024.78453,787,274.52
补充资料:
现金及现金等价物的净增加额-126,569,773.22--20,728,701.58-
TOP↑